Fig. 3From: Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett’s esophagusGraphical representation of TP53 mutations identified in BE and EAC samples. The entire TP53 coding region (exons 2–11) was analyzed by Sanger sequencing, and mutations were found across exons 4–8. The silent mutation R213R found in one BE (patient 13) and one EAC (patient 94) sample was classified as TP53 wild typeBack to article page